ADMA Biologics Stock Forward View - Simple Moving Average
| ADMA Stock | USD 17.30 0.29 1.70% |
ADMA Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast ADMA Biologics stock prices and determine the direction of ADMA Biologics's future trends based on various well-known forecasting models. We suggest always using this module together with an analysis of ADMA Biologics' historical fundamentals, such as revenue growth or operating cash flow patterns.
At this time, the RSI of ADMA Biologics' share price is approaching 49. This suggests that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling ADMA Biologics, making its price go up or down. Momentum 49
Impartial
Oversold | Overbought |
EPS Estimate Next Quarter 0.18 | EPS Estimate Current Year 0.6 | EPS Estimate Next Year 0.94 | Wall Street Target Price 25.6667 | EPS Estimate Current Quarter 0.155 |
Using ADMA Biologics hype-based prediction, you can estimate the value of ADMA Biologics from the perspective of ADMA Biologics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards ADMA Biologics using ADMA Biologics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards ADMA using crowd psychology based on the activity and movement of ADMA Biologics' stock price.
ADMA Biologics Short Interest
A significant increase or decrease in ADMA Biologics' short interest from the previous month could be a good indicator of investor sentiment towards ADMA. Short interest can provide insight into the potential direction of ADMA Biologics stock and how bullish or bearish investors feel about the market overall.
200 Day MA 17.9965 | Short Percent 0.0959 | Short Ratio 8.07 | Shares Short Prior Month 19 M | 50 Day MA 18.3952 |
ADMA Relative Strength Index
The Simple Moving Average forecasted value of ADMA Biologics on the next trading day is expected to be 17.30 with a mean absolute deviation of 0.44 and the sum of the absolute errors of 26.24.ADMA Biologics Hype to Price Pattern
Investor biases related to ADMA Biologics' public news can be used to forecast risks associated with an investment in ADMA. The trend in average sentiment can be used to explain how an investor holding ADMA can time the market purely based on public headlines and social activities around ADMA Biologics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of ADMA Biologics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about ADMA Biologics.
ADMA Biologics Implied Volatility | 0.68 |
ADMA Biologics' implied volatility exposes the market's sentiment of ADMA Biologics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if ADMA Biologics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that ADMA Biologics stock will not fluctuate a lot when ADMA Biologics' options are near their expiration.
The Simple Moving Average forecasted value of ADMA Biologics on the next trading day is expected to be 17.30 with a mean absolute deviation of 0.44 and the sum of the absolute errors of 26.24. ADMA Biologics after-hype prediction price | USD 17.3 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of ADMA Biologics to cross-verify your projections. Prediction based on Rule 16 of the current ADMA contract
Based on the Rule 16, the options market is currently suggesting that ADMA Biologics will have an average daily up or down price movement of about 0.0425% per day over the life of the 2026-04-17 option contract. With ADMA Biologics trading at USD 17.3, that is roughly USD 0.007353 . If you think that the market is fully incorporating ADMA Biologics' daily price movement you should consider acquiring ADMA Biologics options at the current volatility level of 0.68%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-04-17 ADMA Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast ADMA Biologics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in ADMA Biologics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for ADMA Biologics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current ADMA Biologics' open interest, investors have to compare it to ADMA Biologics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of ADMA Biologics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in ADMA. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
ADMA Biologics Additional Predictive Modules
Most predictive techniques to examine ADMA price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for ADMA using various technical indicators. When you analyze ADMA charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
ADMA Biologics Simple Moving Average Price Forecast For the 3rd of February
Given 90 days horizon, the Simple Moving Average forecasted value of ADMA Biologics on the next trading day is expected to be 17.30 with a mean absolute deviation of 0.44, mean absolute percentage error of 0.31, and the sum of the absolute errors of 26.24.Please note that although there have been many attempts to predict ADMA Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that ADMA Biologics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
ADMA Biologics Stock Forecast Pattern
| Backtest ADMA Biologics | ADMA Biologics Price Prediction | Research Analysis |
ADMA Biologics Forecasted Value
In the context of forecasting ADMA Biologics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. ADMA Biologics' downside and upside margins for the forecasting period are 14.34 and 20.26, respectively. We have considered ADMA Biologics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of ADMA Biologics stock data series using in forecasting. Note that when a statistical model is used to represent ADMA Biologics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 113.2714 |
| Bias | Arithmetic mean of the errors | -0.0718 |
| MAD | Mean absolute deviation | 0.4448 |
| MAPE | Mean absolute percentage error | 0.0249 |
| SAE | Sum of the absolute errors | 26.245 |
Predictive Modules for ADMA Biologics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as ADMA Biologics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.ADMA Biologics After-Hype Price Density Analysis
As far as predicting the price of ADMA Biologics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in ADMA Biologics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of ADMA Biologics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
ADMA Biologics Estimiated After-Hype Price Volatility
In the context of predicting ADMA Biologics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on ADMA Biologics' historical news coverage. ADMA Biologics' after-hype downside and upside margins for the prediction period are 14.29 and 20.31, respectively. We have considered ADMA Biologics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
ADMA Biologics is not too volatile at this time. Analysis and calculation of next after-hype price of ADMA Biologics is based on 3 months time horizon.
ADMA Biologics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as ADMA Biologics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading ADMA Biologics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with ADMA Biologics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.32 | 2.96 | 0.04 | 0.70 | 8 Events / Month | 7 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
17.30 | 17.30 | 0.00 |
|
ADMA Biologics Hype Timeline
ADMA Biologics is presently traded for 17.30. The entity has historical hype elasticity of 0.04, and average elasticity to hype of competition of -0.7. ADMA is expected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is expected to be very small, whereas the daily expected return is presently at 0.32%. %. The volatility of related hype on ADMA Biologics is about 135.04%, with the expected price after the next announcement by competition of 16.60. About 94.0% of the company shares are held by institutions such as insurance companies. The company had not issued any dividends in recent years. Given the investment horizon of 90 days the next expected press release will be in about 8 days. Check out Historical Fundamental Analysis of ADMA Biologics to cross-verify your projections.ADMA Biologics Related Hype Analysis
Having access to credible news sources related to ADMA Biologics' direct competition is more important than ever and may enhance your ability to predict ADMA Biologics' future price movements. Getting to know how ADMA Biologics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how ADMA Biologics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ACAD | ACADIA Pharmaceuticals | 0.44 | 10 per month | 1.51 | 0.06 | 3.31 | (2.46) | 9.79 | |
| PRAX | Praxis Precision Medicines | (7.26) | 8 per month | 3.90 | 0.15 | 9.33 | (6.06) | 36.21 | |
| BLTE | Belite Bio ADR | (8.93) | 8 per month | 2.65 | 0.23 | 7.96 | (5.94) | 18.84 | |
| LGND | Ligand Pharmaceuticals Incorporated | (0.84) | 8 per month | 2.08 | (0.0001) | 3.51 | (2.76) | 18.09 | |
| SLNO | Soleno Therapeutics | 0.95 | 9 per month | 0.00 | (0.17) | 5.16 | (4.91) | 28.47 | |
| MIRM | Mirum Pharmaceuticals | 1.33 | 10 per month | 1.70 | 0.21 | 4.60 | (3.38) | 13.83 | |
| DYN | Dyne Therapeutics | (0.37) | 11 per month | 0.00 | (0.09) | 7.01 | (5.90) | 26.40 | |
| CRNX | Crinetics Pharmaceuticals | (6.82) | 10 per month | 2.45 | 0.06 | 3.94 | (4.63) | 19.30 | |
| TLX | Telix Pharmaceuticals Limited | (0.05) | 9 per month | 0.00 | (0.22) | 4.24 | (5.43) | 13.60 | |
| RARE | Ultragenyx | (0.37) | 8 per month | 0.00 | (0.06) | 7.73 | (4.09) | 51.23 |
Other Forecasting Options for ADMA Biologics
For every potential investor in ADMA, whether a beginner or expert, ADMA Biologics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. ADMA Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in ADMA. Basic forecasting techniques help filter out the noise by identifying ADMA Biologics' price trends.ADMA Biologics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ADMA Biologics stock to make a market-neutral strategy. Peer analysis of ADMA Biologics could also be used in its relative valuation, which is a method of valuing ADMA Biologics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
ADMA Biologics Market Strength Events
Market strength indicators help investors to evaluate how ADMA Biologics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading ADMA Biologics shares will generate the highest return on investment. By undertsting and applying ADMA Biologics stock market strength indicators, traders can identify ADMA Biologics entry and exit signals to maximize returns.
ADMA Biologics Risk Indicators
The analysis of ADMA Biologics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in ADMA Biologics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting adma stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.22 | |||
| Semi Deviation | 2.62 | |||
| Standard Deviation | 2.93 | |||
| Variance | 8.58 | |||
| Downside Variance | 7.29 | |||
| Semi Variance | 6.87 | |||
| Expected Short fall | (2.56) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for ADMA Biologics
The number of cover stories for ADMA Biologics depends on current market conditions and ADMA Biologics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that ADMA Biologics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about ADMA Biologics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
ADMA Biologics Short Properties
ADMA Biologics' future price predictability will typically decrease when ADMA Biologics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of ADMA Biologics often depends not only on the future outlook of the potential ADMA Biologics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. ADMA Biologics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 243.3 M | |
| Cash And Short Term Investments | 103.1 M |
Check out Historical Fundamental Analysis of ADMA Biologics to cross-verify your projections. For information on how to trade ADMA Stock refer to our How to Trade ADMA Stock guide.You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ADMA Biologics. If investors know ADMA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive ADMA Biologics assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share 0.88 | Revenue Per Share | Quarterly Revenue Growth 0.12 | Return On Assets | Return On Equity |
ADMA Biologics's market price often diverges from its book value, the accounting figure shown on ADMA's balance sheet. Smart investors calculate ADMA Biologics' intrinsic value—its true economic worth—which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since ADMA Biologics' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Understanding that ADMA Biologics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether ADMA Biologics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. However, ADMA Biologics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.